Mario Gabelli, one of the world’s wealthiest men, revealed 5.42 percent ownership in Orthovita Inc. (NSDQ: VITA) just days before Stryker Corp. (NYSE:SYK) launched its tender offer for the Malvern, Pa.-based orthopedic biologics maker.
MDxHealth wins $1.1 million European grant for cancer research | Funding roundup
Personalized medicine firm MDxHealth SA (BSE:MDXH.BR) and its research partner NovioGendix B.V. won a $1.1 million grant to support the research and development of a new bladder cancer diagnostic.
The funding came from Eurotrans-Bio, a European Commission initiative that supports biotech R&D between companies and academia.
